Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
- PMID:32031570
- PMCID: PMC7042881
- DOI: 10.1001/jama.2020.1585
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Erratum in
- Incorrect Unit of Measure.[No authors listed][No authors listed]JAMA. 2021 Mar 16;325(11):1113. doi: 10.1001/jama.2021.2336.JAMA. 2021.PMID:33724308Free PMC article.No abstract available.
Abstract
Importance: In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited.
Objective: To describe the epidemiological and clinical characteristics of NCIP.
Design, setting, and participants: Retrospective, single-center case series of the 138 consecutive hospitalized patients with confirmed NCIP at Zhongnan Hospital of Wuhan University in Wuhan, China, from January 1 to January 28, 2020; final date of follow-up was February 3, 2020.
Exposures: Documented NCIP.
Main outcomes and measures: Epidemiological, demographic, clinical, laboratory, radiological, and treatment data were collected and analyzed. Outcomes of critically ill patients and noncritically ill patients were compared. Presumed hospital-related transmission was suspected if a cluster of health professionals or hospitalized patients in the same wards became infected and a possible source of infection could be tracked.
Results: Of 138 hospitalized patients with NCIP, the median age was 56 years (interquartile range, 42-68; range, 22-92 years) and 75 (54.3%) were men. Hospital-associated transmission was suspected as the presumed mechanism of infection for affected health professionals (40 [29%]) and hospitalized patients (17 [12.3%]). Common symptoms included fever (136 [98.6%]), fatigue (96 [69.6%]), and dry cough (82 [59.4%]). Lymphopenia (lymphocyte count, 0.8 × 109/L [interquartile range {IQR}, 0.6-1.1]) occurred in 97 patients (70.3%), prolonged prothrombin time (13.0 seconds [IQR, 12.3-13.7]) in 80 patients (58%), and elevated lactate dehydrogenase (261 U/L [IQR, 182-403]) in 55 patients (39.9%). Chest computed tomographic scans showed bilateral patchy shadows or ground glass opacity in the lungs of all patients. Most patients received antiviral therapy (oseltamivir, 124 [89.9%]), and many received antibacterial therapy (moxifloxacin, 89 [64.4%]; ceftriaxone, 34 [24.6%]; azithromycin, 25 [18.1%]) and glucocorticoid therapy (62 [44.9%]). Thirty-six patients (26.1%) were transferred to the intensive care unit (ICU) because of complications, including acute respiratory distress syndrome (22 [61.1%]), arrhythmia (16 [44.4%]), and shock (11 [30.6%]). The median time from first symptom to dyspnea was 5.0 days, to hospital admission was 7.0 days, and to ARDS was 8.0 days. Patients treated in the ICU (n = 36), compared with patients not treated in the ICU (n = 102), were older (median age, 66 years vs 51 years), were more likely to have underlying comorbidities (26 [72.2%] vs 38 [37.3%]), and were more likely to have dyspnea (23 [63.9%] vs 20 [19.6%]), and anorexia (24 [66.7%] vs 31 [30.4%]). Of the 36 cases in the ICU, 4 (11.1%) received high-flow oxygen therapy, 15 (41.7%) received noninvasive ventilation, and 17 (47.2%) received invasive ventilation (4 were switched to extracorporeal membrane oxygenation). As of February 3, 47 patients (34.1%) were discharged and 6 died (overall mortality, 4.3%), but the remaining patients are still hospitalized. Among those discharged alive (n = 47), the median hospital stay was 10 days (IQR, 7.0-14.0).
Conclusions and relevance: In this single-center case series of 138 hospitalized patients with confirmed NCIP in Wuhan, China, presumed hospital-related transmission of 2019-nCoV was suspected in 41% of patients, 26% of patients received ICU care, and mortality was 4.3%.
Conflict of interest statement
Figures


Comment in
- Effective strategies to prevent coronavirus disease-2019 (COVID-19) outbreak in hospital.Lee IK, Wang CC, Lin MC, Kung CT, Lan KC, Lee CT.Lee IK, et al.J Hosp Infect. 2020 May;105(1):102-103. doi: 10.1016/j.jhin.2020.02.022. Epub 2020 Mar 3.J Hosp Infect. 2020.PMID:32142886Free PMC article.No abstract available.
- Novel Coronavirus (COVID-19) Epidemic: What Are the Risks for Older Patients?Garnier-Crussard A, Forestier E, Gilbert T, Krolak-Salmon P.Garnier-Crussard A, et al.J Am Geriatr Soc. 2020 May;68(5):939-940. doi: 10.1111/jgs.16407. Epub 2020 Mar 12.J Am Geriatr Soc. 2020.PMID:32162679Free PMC article.No abstract available.
- Precautions for Intubating Patients with COVID-19.Luo M, Cao S, Wei L, Tang R, Hong S, Liu R, Wang Y.Luo M, et al.Anesthesiology. 2020 Jun;132(6):1616-1618. doi: 10.1097/ALN.0000000000003288.Anesthesiology. 2020.PMID:32195703Free PMC article.No abstract available.
- End-Stage Heart Failure With COVID-19: Strong Evidence of Myocardial Injury by 2019-nCoV.Dong N, Cai J, Zhou Y, Liu J, Li F.Dong N, et al.JACC Heart Fail. 2020 Jun;8(6):515-517. doi: 10.1016/j.jchf.2020.04.001. Epub 2020 Apr 7.JACC Heart Fail. 2020.PMID:32265149Free PMC article.No abstract available.
- Inside the heart of COVID-19.Adão R, Guzik TJ.Adão R, et al.Cardiovasc Res. 2020 May 1;116(6):e59-e61. doi: 10.1093/cvr/cvaa086.Cardiovasc Res. 2020.PMID:32266937Free PMC article.No abstract available.
- Impact of COVID-19: perspectives from gastroenterology.Tay SW, Teh KKJ, Wang LM, Ang TL.Tay SW, et al.Singapore Med J. 2020 Sep;61(9):460-462. doi: 10.11622/smedj.2020051. Epub 2020 Apr 13.Singapore Med J. 2020.PMID:32279480Free PMC article.No abstract available.
- The evidence of SARS-CoV-2 infection on ocular surface.Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W, Yu H, Chen B, Sun X.Zhang X, et al.Ocul Surf. 2020 Jul;18(3):360-362. doi: 10.1016/j.jtos.2020.03.010. Epub 2020 Apr 11.Ocul Surf. 2020.PMID:32289466Free PMC article.
- Anosmia in a healthcare worker with COVID-19 in Madrid, Spain.Ollarves-Carrero MF, Rodriguez-Morales AG, Bonilla-Aldana DK, Rodriguez-Morales AJ.Ollarves-Carrero MF, et al.Travel Med Infect Dis. 2020 May-Jun;35:101666. doi: 10.1016/j.tmaid.2020.101666. Epub 2020 Apr 13.Travel Med Infect Dis. 2020.PMID:32298782Free PMC article.No abstract available.
- The importance of hypertension as a risk factor for severe illness and mortality in COVID-19.Cook TM.Cook TM.Anaesthesia. 2020 Jul;75(7):976-977. doi: 10.1111/anae.15103. Epub 2020 May 9.Anaesthesia. 2020.PMID:32339251Free PMC article.No abstract available.
- COVID-19 and vitamin D deficiency, a fatal combination?van der Meulen J.van der Meulen J.Neth J Med. 2020 Jul;78(4):218.Neth J Med. 2020.PMID:32641560No abstract available.
- Effect of age on death due to coronavirus disease 2019 (COVID-19): Application of Poisson regression model.Talukder A.Talukder A.Int J Clin Pract. 2020 Nov;74(11):e13649. doi: 10.1111/ijcp.13649.Int J Clin Pract. 2020.PMID:32757345Free PMC article.No abstract available.
- Electrocardiography Holter monitoring in critically ill patients with coronavirus disease 2019 (COVID-19).Laleh Far V, Mehrakizadeh A, Eslami M, Shirazi S, Mohammadi M, Mollazadeh R.Laleh Far V, et al.Pol Arch Intern Med. 2020 Nov 30;130(11):1010-1012. doi: 10.20452/pamw.15601. Epub 2020 Sep 15.Pol Arch Intern Med. 2020.PMID:32930544No abstract available.
- The role of probiotics in COVID-19 treatment: Gut microbiota can help physicians in the outbreak.Şahin M.Şahin M.Turk J Gastroenterol. 2020 Oct;31(10):724-725. doi: 10.5152/tjg.2020.20338.Turk J Gastroenterol. 2020.PMID:33169711Free PMC article.No abstract available.
References
- Wuhan Municipal Health Commission Report of novel coronavirus-infected pneumonia in China. Published January 20, 2020. Accessed January 31, 2020.http://wjw.wuhan.gov.cn/front/web/showDetail/2020012009077
- Wuhan Municipal Health Commission Report of clustering pneumonia of unknown etiology in Wuhan City. Published December 31, 2019. Accessed January 31, 2020.http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
